DIMENSIONAL FUND ADVISORS LP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 192 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$53,127,911
-11.0%
5,516,976
-1.7%
0.02%
-10.5%
Q2 2023$59,701,981
+23.1%
5,611,068
+21.7%
0.02%
+18.8%
Q1 2023$48,486,599
+106743.4%
4,609,079
+25.8%
0.02%
+23.1%
Q4 2022$45,381
-99.9%
3,662,598
+9.9%
0.01%0.0%
Q3 2022$34,515,000
-2.8%
3,331,623
+8.2%
0.01%0.0%
Q2 2022$35,506,000
-8.2%
3,079,290
+0.2%
0.01%
+8.3%
Q1 2022$38,678,000
+7.8%
3,074,530
-0.1%
0.01%
+9.1%
Q4 2021$35,878,000
-7.1%
3,076,989
+4.1%
0.01%
-8.3%
Q3 2021$38,621,000
+12.0%
2,957,073
+10.4%
0.01%
+9.1%
Q2 2021$34,485,000
+58.6%
2,679,530
+37.8%
0.01%
+57.1%
Q1 2021$21,741,000
+46.0%
1,944,699
+48.7%
0.01%
+40.0%
Q4 2020$14,892,000
+63.1%
1,307,399
+28.8%
0.01%
+25.0%
Q3 2020$9,130,000
+1.3%
1,014,738
+16.1%
0.00%0.0%
Q2 2020$9,017,000
+73.7%
873,816
+69.9%
0.00%
+33.3%
Q1 2020$5,190,000
+195.9%
514,204
+290.2%
0.00%
+200.0%
Q4 2019$1,754,000
+596.0%
131,795
+440.8%
0.00%
Q4 2018$252,000
+2420.0%
24,371
+3744.0%
0.00%
Q4 2014$10,000
+25.0%
6340.0%0.00%
Q3 2014$8,000
-20.0%
6340.0%0.00%
Q2 2014$10,000
+25.0%
6340.0%0.00%
Q1 2014$8,0006340.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders